HSBC Life UK adds less advanced prostate cancer, Parkinson’s Disease, pregnancy complications and top up payments to CI

HSBC Life UK is broadening its critical illness (CI) cover to include less advanced prostate cancer and Parkinson’s Disease and adding cover for seven types of pregnancy complications.

The updates form part of a raft of changes to the insurer’s CI cover which include:

In July, Chesnara entered into an agreement to acquire HSBC Life (UK) Ltd for £260m.

Completion is expected in early 2026, subject to customary regulatory approvals.

Helping more people facing difficult health diagnoses

Richard Waters, head of protection distribution at HSBC Life UK, said: “We have considered feedback and insight from advisers, customers and industry experts and developed a series of enhancements that ensure we can financially assist more people who are facing difficult health diagnoses.

“According to research, 45% of advisers said their clients would be more likely to purchase critical illness cover if a pay out was made as soon as they were added to the NHS waiting list. Furthermore, 60% of advisers said if additional/severity payments were paid quickly enough to pay for private treatment, their clients would be more likely to buy critical illness cover.

“Lastly, 67% of advisers said if their clients received a payment quickly enough to pay for private treatment for early-stage cancers, they’d be more likely to buy critical illness cover.

“Our critical illness pay out rate of 94.4% last year highlights our commitment to paying claims and our latest enhancements will make customers more financially resilient.”

Impressive series of improvements

Providing his take on the changes, Alan Lakey, director at CIExpert, said: “These improvements are significant in that they extend the claim potential due to the NHS waiting list coverage and they also reflect the long-term financial impact of suffering certain conditions prior to age 60.

“The introduction of pregnancy complications, that also extends to the life insured’s partner, reflects the impact to the family as opposed to the individual.

“Our Critical Thinking research identified concerns amongst consumers about delay in treatment from the NHS, and the introduction of accelerated payments for less advanced cancers is an innovation that will provide significant value for clients going forward as individuals are increasingly considering private treatment to avoid long delays and the potential for their health to deteriorate further whilst they are waiting.

“An impressive and well-thought-out series of improvements which will push both plans up the quality table.”

Exit mobile version